vs
AdvanSix Inc.（ASIX）与Doximity, Inc.（DOCS）财务数据对比。点击上方公司名可切换其他公司
AdvanSix Inc.的季度营收约是Doximity, Inc.的1.9倍（$359.9M vs $185.1M），Doximity, Inc.净利率更高（33.3% vs -0.8%，领先34.0%），Doximity, Inc.同比增速更快（9.8% vs 9.4%），过去两年Doximity, Inc.的营收复合增速更高（25.2% vs 3.4%）
AdvanSix Inc.是一家美国化工企业，主营尼龙6以及己内酰胺、硫酸铵肥料等相关化工产品。该公司原为霍尼韦尔旗下树脂与化工事业部，于2016年分拆独立，2019年预估营收达14亿美元，其企业历史可追溯至1884年在宾夕法尼亚州法兰克福成立的H. W. Jayne公司。
Doximity Inc成立于2010年，是面向医疗专业人士的线上社交服务平台，为平台会员提供精选医疗资讯、远程医疗工具，以及病例协作相关功能，助力医疗从业者高效交流信息、开展诊疗相关工作。
ASIX vs DOCS — 直观对比
营收规模更大
ASIX
是对方的1.9倍
$185.1M
营收增速更快
DOCS
高出0.4%
9.4%
净利率更高
DOCS
高出34.0%
-0.8%
两年增速更快
DOCS
近两年复合增速
3.4%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $359.9M | $185.1M |
| 净利润 | $-2.8M | $61.6M |
| 毛利率 | 7.6% | 89.9% |
| 营业利润率 | -0.7% | 38.9% |
| 净利率 | -0.8% | 33.3% |
| 营收同比 | 9.4% | 9.8% |
| 净利润同比 | -892.9% | -18.1% |
| 每股收益（稀释后） | $-0.11 | $0.31 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASIXDOCS
| Q4 25 | $359.9M | $185.1M | ||
| Q3 25 | $374.5M | $168.5M | ||
| Q2 25 | $410.0M | $145.9M | ||
| Q1 25 | $377.8M | $138.3M | ||
| Q4 24 | $329.1M | $168.6M | ||
| Q3 24 | $398.2M | $136.8M | ||
| Q2 24 | $453.5M | $126.7M | ||
| Q1 24 | $336.8M | $118.1M |
净利润ASIXDOCS
| Q4 25 | $-2.8M | $61.6M | ||
| Q3 25 | $-2.6M | $62.1M | ||
| Q2 25 | $31.4M | $53.3M | ||
| Q1 25 | $23.3M | $62.5M | ||
| Q4 24 | $352.0K | $75.2M | ||
| Q3 24 | $22.3M | $44.2M | ||
| Q2 24 | $38.9M | $41.4M | ||
| Q1 24 | $-17.4M | $40.6M |
毛利率ASIXDOCS
| Q4 25 | 7.6% | 89.9% | ||
| Q3 25 | 6.8% | 90.3% | ||
| Q2 25 | 14.3% | 89.2% | ||
| Q1 25 | 14.2% | 89.5% | ||
| Q4 24 | 3.4% | 91.6% | ||
| Q3 24 | 14.4% | 90.0% | ||
| Q2 24 | 17.9% | 89.3% | ||
| Q1 24 | 0.9% | 89.4% |
营业利润率ASIXDOCS
| Q4 25 | -0.7% | 38.9% | ||
| Q3 25 | -0.9% | 37.8% | ||
| Q2 25 | 7.7% | 37.4% | ||
| Q1 25 | 7.7% | 35.2% | ||
| Q4 24 | -3.9% | 47.4% | ||
| Q3 24 | 7.5% | 38.8% | ||
| Q2 24 | 11.5% | 36.4% | ||
| Q1 24 | -7.0% | 35.5% |
净利率ASIXDOCS
| Q4 25 | -0.8% | 33.3% | ||
| Q3 25 | -0.7% | 36.8% | ||
| Q2 25 | 7.7% | 36.5% | ||
| Q1 25 | 6.2% | 45.2% | ||
| Q4 24 | 0.1% | 44.6% | ||
| Q3 24 | 5.6% | 32.3% | ||
| Q2 24 | 8.6% | 32.7% | ||
| Q1 24 | -5.2% | 34.4% |
每股收益（稀释后）ASIXDOCS
| Q4 25 | $-0.11 | $0.31 | ||
| Q3 25 | $-0.10 | $0.31 | ||
| Q2 25 | $1.15 | $0.27 | ||
| Q1 25 | $0.86 | $0.31 | ||
| Q4 24 | $0.02 | $0.37 | ||
| Q3 24 | $0.82 | $0.22 | ||
| Q2 24 | $1.43 | $0.21 | ||
| Q1 24 | $-0.65 | $0.20 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $19.8M | $64.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $815.2M | $979.3M |
| 总资产 | $1.7B | $1.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASIXDOCS
| Q4 25 | $19.8M | $64.8M | ||
| Q3 25 | $23.7M | $169.2M | ||
| Q2 25 | $18.4M | $137.3M | ||
| Q1 25 | $8.3M | $209.6M | ||
| Q4 24 | $19.6M | $165.3M | ||
| Q3 24 | $17.3M | $184.2M | ||
| Q2 24 | $12.1M | $111.4M | ||
| Q1 24 | $20.6M | $96.8M |
股东权益ASIXDOCS
| Q4 25 | $815.2M | $979.3M | ||
| Q3 25 | $818.2M | $1.1B | ||
| Q2 25 | $823.7M | $1.0B | ||
| Q1 25 | $794.4M | $1.1B | ||
| Q4 24 | $774.6M | $1.0B | ||
| Q3 24 | $766.4M | $961.2M | ||
| Q2 24 | $746.6M | $913.6M | ||
| Q1 24 | $713.2M | $901.4M |
总资产ASIXDOCS
| Q4 25 | $1.7B | $1.2B | ||
| Q3 25 | $1.7B | $1.3B | ||
| Q2 25 | $1.6B | $1.2B | ||
| Q1 25 | $1.6B | $1.3B | ||
| Q4 24 | $1.6B | $1.2B | ||
| Q3 24 | $1.5B | $1.1B | ||
| Q2 24 | $1.5B | $1.1B | ||
| Q1 24 | $1.5B | $1.1B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $63.7M | $60.9M |
| 自由现金流经营现金流 - 资本支出 | $36.1M | — |
| 自由现金流率自由现金流/营收 | 10.0% | — |
| 资本支出强度资本支出/营收 | 7.7% | — |
| 现金转化率经营现金流/净利润 | — | 0.99× |
| 过去12个月自由现金流最近4个季度 | $6.4M | — |
8季度趋势，按日历期对齐
经营现金流ASIXDOCS
| Q4 25 | $63.7M | $60.9M | ||
| Q3 25 | $26.6M | $93.9M | ||
| Q2 25 | $21.1M | $62.1M | ||
| Q1 25 | $11.4M | $98.5M | ||
| Q4 24 | $64.2M | $65.2M | ||
| Q3 24 | $57.3M | $68.3M | ||
| Q2 24 | $50.2M | $41.2M | ||
| Q1 24 | $-36.2M | $63.9M |
自由现金流ASIXDOCS
| Q4 25 | $36.1M | — | ||
| Q3 25 | $66.0K | — | ||
| Q2 25 | $-7.2M | — | ||
| Q1 25 | $-22.6M | — | ||
| Q4 24 | $29.8M | — | ||
| Q3 24 | $26.8M | — | ||
| Q2 24 | $16.7M | — | ||
| Q1 24 | $-71.6M | — |
自由现金流率ASIXDOCS
| Q4 25 | 10.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | -1.7% | — | ||
| Q1 25 | -6.0% | — | ||
| Q4 24 | 9.1% | — | ||
| Q3 24 | 6.7% | — | ||
| Q2 24 | 3.7% | — | ||
| Q1 24 | -21.3% | — |
资本支出强度ASIXDOCS
| Q4 25 | 7.7% | — | ||
| Q3 25 | 7.1% | — | ||
| Q2 25 | 6.9% | — | ||
| Q1 25 | 9.0% | 0.0% | ||
| Q4 24 | 10.4% | 0.0% | ||
| Q3 24 | 7.7% | 0.0% | ||
| Q2 24 | 7.4% | 0.0% | ||
| Q1 24 | 10.5% | 0.0% |
现金转化率ASIXDOCS
| Q4 25 | — | 0.99× | ||
| Q3 25 | — | 1.51× | ||
| Q2 25 | 0.67× | 1.16× | ||
| Q1 25 | 0.49× | 1.58× | ||
| Q4 24 | 182.29× | 0.87× | ||
| Q3 24 | 2.57× | 1.55× | ||
| Q2 24 | 1.29× | 1.00× | ||
| Q1 24 | — | 1.57× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
DOCS
| Subscription | $175.4M | 95% |
| Service Other | $9.7M | 5% |
